DIOSynVax
About:
DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.
Website: http://diosvax.com/
Top Investors: Innovate UK, Parkwalk Advisors, Coalition for Epidemic Preparedness Innovations
Description:
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
Total Funding Amount:
$46.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2017-01-01
Contact Email:
enquiries(AT)diosvax.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2022-03-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai